DraftKings to Release First Quarter 2024 Results on May 2, 2024 and Host Conference Call on May 3, 2024
BOSTON, April 15, 2024 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it will […]
Abits Group Receives NASDAQ Notification Regarding Minimum Bid Price Requirements
Hong Kong, April 15, 2024 (GLOBE NEWSWIRE) — Abits Group Inc (the “Company”) (NASDAQ: ABTS), a company engaged in bitcoin […]
RYVYL Inc. Announces Launch of Proposed Underwritten Public Offering
San Diego, CA, April 15, 2024 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”), a leading innovator […]
Vince Tyra, chef de la direction de Les Vêtements de Sport Gildan, présente ses principales priorités stratégiques
La Société confirme ses prévisions pour l’exercice 2024 complet Annonce des produits préliminaires du premier trimestre de [...]
Gildan Activewear CEO Vince Tyra provides key focus strategic priorities
Company Reconfirms 2024 Full Year GuidanceAnnounces Preliminary Q1 2024 RevenueCompany to Host Investor Day in Fall 2024 MONTREAL, April 15, […]
Beneficient to Participate in the Planet MicroCap Showcase on May 1-2, 2024
DALLAS, April 15, 2024 (GLOBE NEWSWIRE) — Beneficient (Nasdaq: BENF) (together with its affiliates, “Ben” or the “Company”), a technology-enabled […]
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
Initiated multiple Phase 1b expansion cohorts to determine the RP2D of ORIC-114 in NSCLC patients with EGFR exon 20, HER2 […]
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the […]
TSX News -
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company […]
Tidewater Utilities Announces Strategy for Compliance With New EPA PFAS Regulation
DOVER, Del., April 15, 2024 (GLOBE NEWSWIRE) — Tidewater Utilities, Inc., (Tidewater) a wholly owned subsidiary of Middlesex Water Company (NASDAQ: […]
